Sign inJoin waitlistJoin the waitlist

Nisha A. Mohindra

Professor, Feinberg School of Medicine · Feinberg School of Medicine

Credentials: · · · ·

History

Feinberg School of Medicine
Present

McGaw Medical Center of Northwestern University
Until 2015
McGaw Medical Center of Northwestern University
Until 2012
University of Texas Southwestern Medical School
2009

Research

Management of Immunotherapy-Related Toxicities, Version 1.2019
Journal of the National Comprehensive Cancer Network · 2019 · 447 citations
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 442 citations
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
Review · Journal of the National Comprehensive Cancer Network · 2022 · 415 citations

Sheetal Kircher
14 papers
Young Chae
14 papers
David Cella
12 papers
FG
Francis Giles
10 papers
VV
Victoria Villaflor
8 papers
Jeffrey Sosman
6 papers
Jyoti Patel
6 papers
Lisa Hirschhorn
6 papers
Sofia Garcia
6 papers
Jeffrey Linder
5 papers
Sandip Patel
5 papers
Vikram Aggarwal
5 papers

Clinical trials

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC
Study chair · Terminated · Phase 1, Phase 2
Nisha Mohindra, MD
2015–2022
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
Site PI · Recruiting · Phase 2
PrECOG, LLC.
2026–2030
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2020–2026